ACFrOgB7rImjpvLS FikkMUc80bJDiZ7lXY7kKvsp9pDWn-DFuycxndjiDpbXoLTIV-A4-UpOdFNucV76yIk 80vdEucAvEFNtCP7HqfqwQ0lpNv GQaUkpk58xoLs8 BIMMZV7IpAinEj7R3hb3

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 7

PO No :PO2104356416-107

Name : Mr.YASHRAJ SINGH Client Name : TATA 1MG OKHLA


Age/Gender : 24/Male Registration Date : 22-Dec-23 12:14 PM
Patient ID : OKH1085046 Collection Date : 22/Dec/2023 10:18AM
Barcode ID/Order ID : D7734286 / 8657527 Sample Receive Date : 23/Dec/2023 09:35AM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 23/Dec/2023 10:46AM

Immunology
LH & FSH
Test Name Result Unit Bio. Ref. Interval Method

Follicle Stimulating Hormone (FSH) 1.4 mIU/mL 1.4 - 18.1 CLIA

Comment:
Interpretation: FSH and LH are glycoprotein hormones which play a critical role in maintaining the normal function of the male
and female reproductive systems.FSH levels vary throughout the menstrual cycle in response to estradiol and progesterone.

Testing is useful for :

Predicting ovulation
Evaluating infertility
Diagnosing pituitary disorders.
An adjunct in the evaluation of menstrual irregularities
Evaluating patients with suspected hypogonadism

Increased FSH in :

Menopause
Primary gonadal failure
Complete testicular feminization syndrome
Precocious puberty (either idiopathic or secondary to a central nervous system lesion)
Primary ovarian hypofunction in females
Primary hypogonadism in males
Gonadotrophin secreting pituitary tumours.
Drugs

Normal or decreased FSH in:

Drugs (Oral contraceptive pills and Steroids)


Pregnancy
Ectopic steroid hormone production
Anorexia nervosa.
Poly cystic ovarian disease
Pituitary or hypothalamus failure

Page 1 of 6
PO No :PO2104356416-107

Name : Mr.YASHRAJ SINGH Client Name : TATA 1MG OKHLA


Age/Gender : 24/Male Registration Date : 22-Dec-23 12:14 PM
Patient ID : OKH1085046 Collection Date : 22/Dec/2023 10:18AM
Barcode ID/Order ID : D7734286 / 8657527 Sample Receive Date : 23/Dec/2023 09:35AM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 23/Dec/2023 11:47AM

Immunology
Test Name Result Unit Bio. Ref. Interval Method

Testosterone Total
Testosterone, total 677.83 ng/dL 240.24-870.68 CMIA

Comment:
Stage Male Female
Tanner Stage I 2.52 - 29.29 ng/dL 1.18 - 32.30 ng/dL
Tanner Stage II 3.86 - 278.59 ng/dL 5.05 - 22.21 ng/dL
Tanner Stage III 8.91- 655.39 ng/dL 7.43 - 41.24 ng/dL
Tanner Stage IV 19.96 - 754.45 ng/dL 15.19 - 53.64 ng/dL
Tanner Stage V 16.64 - 902.09 ng/dL 17.02 - 98.78 ng/dL

Testosterone is the major androgen in males produced by the Leydig cells of the testes.In females, it is secreted by
adrenal cortex and ovaries.
In serum, testosterone is largely bound to a specific steroid hormone-binding globulin (SHBG) (60%and to albumin (38%),
but it is the free hormone (2%) that is physiologically active.
The total testosterone level measures both bound and free testosterone in the serum.

Increased in: Idiopathic sexual precocity, adrenal hyperplasia (boys), adrenocortical tumors, trophoblastic disease during
pregnancy, idiopathic hirsutism, virilizing ovarian tumors, PCOD, arrhenoblastoma, virilizing luteoma, testicular feminization
(normal or moderately elevated), hyperthyroidism, Cushing’s Disease, drugs (anticonvulsants, barbiturates, estrogens, oral
contraceptives).

Decreased in: Hypogonadism (primary and secondary), orchidectomy, Klinefelter syndrome, uremia, hemodialysis, hepatic
insufficiency, ethanol, drugs (digoxin, spironolactone, acarbose), excessive exercise.

Note

Free testosterone should be measured in symptomatic patients with normal total testosterone levels.
In men, there is a diurnal variation in serum testosterone with a 20% elevation in levels in the evenings.
Physiological episodic secretion of testosterone may lead to variation in serum levels.
Time of day, age, sex, puberty, pre & post menopause have an influence on testosterone concentration.
Please note test values may very depending on the assay method used.

Page 2 of 6
PO No :PO2104356416-107

Name : Mr.YASHRAJ SINGH Client Name : TATA 1MG OKHLA


Age/Gender : 24/Male Registration Date : 22-Dec-23 12:14 PM
Patient ID : OKH1085046 Collection Date : 22/Dec/2023 10:18AM
Barcode ID/Order ID : D7734286 / 8657527 Sample Receive Date : 23/Dec/2023 09:35AM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 23/Dec/2023 10:33AM

Immunology
Test Name Result Unit Bio. Ref. Interval Method

Thyroid Profile
T3, Total 0.98 ng/mL 0.60-1.81 CLIA
T4, Total 8.1 µg/dl 4.5-12.6 CLIA
Thyroid Stimulating Hormone - Ultra
1.287 uIU/ml 0.55-4.78 CLIA
Sensitive

Comment:

Below mentioned are the guidelines for pregnancy related reference ranges for TSH, total T3 & Total T4.

Pregnancy
TSH (μIU/mL) (as per
American Thyroid Total T3 (ng/mL) Total T4(μg/dL)
Association )
1st trimester 0.1-2.5 0.81-1.90 7.33-14.8
2nd trimester 0.2-3.0 1.00-2.60 7.93-16.1
3rd trimester 0.3-3.0 1.00-2.60 6.95-15.7

TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a minimum between 6-10 pm
.
The variation is of the order of 50%, hence time of the day has influence on the measured serum TSH concentrations.
TSH is secreted in a dual fashion: Intermittent pulses constitute 60-70% of total amount, background continuous secretion
is 30-40%.These pulses occur regularly every 1-3 hrs.
Total T3 & T4 concentrations are altered by physiological or pathological changes in thyroxine binding globulin (TBG)
capacity .
The determination of free T3 & free T4 has the advantage of being independent of changes in the concentrations and
binding properties of the binding proteins.
Changes in thyroid status are typically associated with concordant changes in T3, T4 and TSH levels.
Unexpectedly abnormal or discordant thyroid test values may be seen with some rare, but clinically significant conditions
such as central hypothyroidism, TSH-secreting pituitary tumors, thyroid hormone resistance, or the presence of
heterophilic antibodies (HAMA) or thyroid hormone autoantibodies.
For diagnostic purposes, results should be used in conjunction with other data.

TSH T3 T4 Interpretation

Page 3 of 6
PO No :PO2104356416-107

Name : Mr.YASHRAJ SINGH Client Name : TATA 1MG OKHLA


Age/Gender : 24/Male Registration Date : 22-Dec-23 12:14 PM
Patient ID : OKH1085046 Collection Date : 22/Dec/2023 10:18AM
Barcode ID/Order ID : D7734286 / 8657527 Sample Receive Date : 23/Dec/2023 09:35AM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 23/Dec/2023 10:33AM

Immunology
Test Name Result Unit Bio. Ref. Interval Method

High Normal Normal Subclinical Hypothyroidism


Low Normal Normal Subclinical Hyperthyroidism
High High High Secondary Hyperthyroidism
Low High/Normal High/Normal Hyperthyroidism
Non thyroidal illness / Secondary
Low Low Low Hypothyroidism

Page 4 of 6
PO No :PO2104356416-107

Name : Mr.YASHRAJ SINGH Client Name : TATA 1MG OKHLA


Age/Gender : 24/Male Registration Date : 22-Dec-23 12:14 PM
Patient ID : OKH1085046 Collection Date : 22/Dec/2023 10:18AM
Barcode ID/Order ID : D7734286 / 8657527 Sample Receive Date : 23/Dec/2023 09:35AM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 23/Dec/2023 10:38AM

Immunology
LH & FSH
Test Name Result Unit Bio. Ref. Interval Method

Children : <0.1- 6.0


Luteinizing Hormone (LH) 5.18 mIU/mL 20 -70 years : 1.5 - 9.3 CLIA
>70 years: 3.1 - 34.6

Comment:
Interpretation: FSH and LH are glycoprotein hormones which play a critical role in maintaining the normal function of the male
and female reproductive systems.

Testing is useful for :

Predicting ovulation
Evaluating infertility
Diagnosing pituitary disorders.
An adjunct in the evaluation of menstrual irregularities
Evaluating patients with suspected hypogonadism

Increased LH in :

Menopause
Polycystic Ovarian disease.
Endometriosis
Primary gonadal failure
Complete testicular feminization syndrome
Precocious puberty (either idiopathic or secondary to a central nervous system lesion)
Primary ovarian hypofunction in females
Primary hypogonadism in males
Gonadotrophin secreting pituitary tumors.

Decreased LH in :

Anorexia nervosa
Ectopic steroid hormone production
GnRH Analog treatment
Drugs(Digoxin,Oral contraceptive pills ,Phenothiazines)
Advanced Prostate cancer.

Page 5 of 6
PO No :PO2104356416-107

Name : Mr.YASHRAJ SINGH Client Name : TATA 1MG OKHLA


Age/Gender : 24/Male Registration Date : 22-Dec-23 12:14 PM
Patient ID : OKH1085046 Collection Date : 22/Dec/2023 10:18AM
Barcode ID/Order ID : D7734286 / 8657527 Sample Receive Date : 23/Dec/2023 09:35AM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 23/Dec/2023 10:38AM

Immunology
LH & FSH
Test Name Result Unit Bio. Ref. Interval Method
Primary hypergonadism in males
Primary ovarian hyperfunction in females
In failure of pituitary or hypothalamus

*** End Of Report ***

Page 6 of 6
TATA1mg Labs
NABL certificate
and Scope

THANK YOU
for choosing us as your healthcare partner
Tata 1mg Labs, India's trusted diagnostics lab chain, is serving over a million customers each year across
50+ cities. We offer a broad range of tests through an extensive catalog and cutting-edge technology. Our
commitment to providing high-quality healthcare is supported by 11 state-of-the-art laboratories, ensuring
easy access to our services across the country.

Q Delhi (National Reference Lab) Q Gurgaon Q Mumbai Q Pune Q Kolkata

Q Lucknow Q Ahmadabad Q Bangalore Q Chennai Q Hyderabad Q Dehradun

Our Promise
Hygienic In accordance with Expert team Doctor-verified
sample international norms & of medical reports with 3-step
collection clinical safetystandards professionals review process

Get FREE doctor consultation


on every lab test
Watch how
1A1A@ilto
Consult top doctors we take care of
from the comfort of your home your sample

CLAIM NOW>

Introducing TATA 1mg

Cancer Care Platf Need more help?


One stop for comprehensive cancer assistance
Information on specialty medicines, oncologists in your city, Callon
diagnostic tests, PSPs & more
1800-102-1618
EXPLORE NOW >

Conditions of Laboratory Testing & Reporting:


Test results released pertain to the sample, as received. laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be
clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary
depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail
your queries related to test results to Customer Care mall ID cs.labs@lmg.com

Disclaimer: Results re/ate only to the sample received. Test results marked "BOLD" indicate abnormal results i.e. higher or lower than normal. All lab test
results are subject to clinical interpretation by a qualified medico/ professional. This report cannot be used for any medico-legal purposes. Partial
reproduction of the test results is not permitted. Also, TA TA 1mg Lobs is not responsible for any misinterpretation or misuse of the information. The test
reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by o qualified doctor only.

You might also like